|
HEALTH EFFECTS:
Fluoride & Osteocytes
DIRECTORY: FAN
> Health >
Bone >
Cellular
> Osteoblasts
Fluoride & Osteocytes
1) Fluoride's Impact on Osteocytes
2) Mechanism by which Fluoride May Damage Osteocytes
3) Osteocytes: Maintaining
the Structural Health of Bone
1) Fluoride's Impacts
on Osteocytes: (back to top)
"The increased amount of trabecular bone in fluoride therapy
is claimed to be the morphologic expression for fluoride as a
stimulus for bone formation. We propose that the increased amount
of trabecular bone results from pathological
bone formation by injured osteoblasts and decreased bone resorption
by resorbing osteocytes and osteoclasts."
SOURCE: Krook L, Minor RR. (1998). Fluoride and alkaline phosphatase.
Fluoride 31: 177-182.
"Some osteocyte lacunae in this zone were
larger, more rounded, and irregularly arranged."
SOURCE: Ream LJ, et al. (1983). Fluoride ingestion during multiple
pregnancies and lactations: microscopic observations on bone of
the rat. Virchows Arch [Cell Pathol] 44: 35-44.
"osteoblasts that survive as osteocytes
are visibly abnormal."
SOURCE: Riggs BL. (1983). Treatment of osteoporosis with sodium
fluoride: An appraisal. Bone and Mineral Research. 2: 366-393.
"Also noted were
focal irregular arrangement of the osteocytes in 90% of the therapy
group."
SOURCE: Vigorita VJ, Suda MK. (1983). The microscopic morphology
of fluoride-induced bone. Clinical Orthopaedics and Related
Research 177:274-282.
"The characteristics of (fluorotic) bone suggest an active,
but irregular, metabolic process. Osteocytic cellularity, although
significantly present in this group, may occur in a number of
pathologic conditions, including most hypermetabolic areas, e.g.
Paget's disease and hyperparathyroidism. These conditions may
also show an irregular spatial distribution
of osteocytes, a change found to a statistically significant degree
in the (fluoride) therapy group, providing further evidence of
an abnormal metabolic state."
SOURCE: Vigorita VJ, Suda MK. (1983).
The microscopic morphology of fluoride-induced bone. Clinical
Orthopaedics and Related Research 177:274-282.
"The primary target of fluoride was shown
to be the resorbing osteocyte."
SOURCE: Krook L, Maylin GA. (1979). Industrial fluoride pollution.
Chronic fluoride poisoning in Cornwall Island cattle. Cornell
Veterinarian 69(Suppl 8): 1-70.
"The toxic effect of fluoride on the osteocytes
then could go one step further to cause necrosis of the cells.
Sometimes only empty lacunae were observed but with the architecture
of bone still recognizable."
SOURCE: Krook L, Maylin GA. (1979). Industrial fluoride pollution.
Chronic fluoride poisoning in Cornwall Island cattle. Cornell
Veterinarian 69(Suppl 8): 1-70.
"Marked alterations in the fine structure
of osteocytes are produced under the influence of the F diet.
Large distensions of the endoplasmic reticulum and distorsions
of ribosomal patterns are observed in the electron micrographs.
These changes could influence the quality of the organic perilacunar
matrix and its mineralization, and explain the presence of the
uncalcified or poorly calcified perilacunar 'halo' also observed
in the electron micrographs."
SOURCE: Baud CA, Bang S. (1970). Fluoride and bone mineral substance.
In: TL Vischer, ed. (1970). Fluoride in Medicine. Hans Huber,
Bern. pp. 27-36.
"The osteons show the irregularly distributed mineral salts
and irregularly arranged osteocytes which
tend to accumulate at the periphery of the osteon."
SOURCE: Freitag V, et al. (1970). Fluoride content and microradiograph
findings in skeletal fluorosis. Fluoride 3: 167-174.
"Mineralization was particularly deficient
around the osteocyte lacunae as visualized by the porosity picture."
SOURCE: Kuhlencordt F, et al. (1970). The histological evaluation
of bone in fluoride treated osteoorosis. In: TL Vischer, ed. (1970).
Fluoride in Medicine. Hans Huber, Bern.pp. 169-174.
"The osteocyte lacunae were larger than
normal and in some areas these large lacunae were confluent."
SOURCE: Ramberg CF, Olsson SE. (1970). Fluoride effects on bone
morphology and calcium kinetics. Fluoride 3: 175-181.
"The lack of mineralization around osteocyte
lacunae was also evident in all samples..."
Jowsey J, et al. (1968). Some results of the effect of fluoride
on bone tissue in osteoporosis. Journal of Clinical Endocrinology
28:869-874.
"The process of mineralization at the mineralizing front
probably requires normally functioning osteoblasts and osteocytes.
Degenerating osteocytes were found occasionally
in the peripheral portion of wide osteoid seams and also in the
adjacent mineralizing front. In addition, the lacunae and the
canaliculi of osteoid osteocytes were sometimes larger than those
in nonfluorotic bone. Thus, diminished or altered
osteocyte function in this region may have also contributed to
a decreased mineralization rate."
SOURCE: Baylink DJ, Bernstein DS. (1967). The effects of fluoride
therapy on metabolic bone disease. Clinical Orthopaedics and
Related Research 55: 51-85.
"An increased number of microfractures
was frequently found in fluorotic bone. In nonfluorotic
and fluorotic bone, microfractures were usually located in highly
mineralized areas of old bone with an increased number of dead
osteocytes... [D]ead and degenerating osteocytes
were found frequently in the region of microfractures, and viable
osteocytes appear to be necessary for the optimum mechanical function
of bone. It is possible that osteocytes are involved in
the maintenance of structural integrity at an ultra-microscopic
level and that impaired osteocyte function increases the tendency
for small defects to become microfractures."
SOURCE: Baylink DJ, Bernstein DS. (1967). The effects of fluoride
therapy on metabolic bone disease. Clinical
Orthopaedics and Related Research 55: 51-85.
2) Mechanism by which
fluoride may damage Osteocytes (Bone F Accumulation): (back
to top)
"[B]one cells would not be exposed to high concentrations
(of fluoride) when they [a]re not resorbing bone. However, it
is evident that any cells which resorb bone necessarily would
be thereby exposed to a significant concentration of fluoride.
This specific exposure would hold for osteocytes and osteoclasts
throughout bone, both of which would be subjected to a concentration
of fluoride which would be approximately proportionate to the
intensity of the resorptive process. It could
be speculated that the exposure of osteocytes, which are entirely
surrounded by a surface on which fluoride probably is concentrated
and which exist farther away from the blood stream, would be subjected
to a higher concentration of fluoride upon resorbing bone than
would be the osteoclasts. What fluoride does to these cells
is unknown. We believe the action on bone cells
would be a toxic one and that the consequence of a high
regional concentration of fluoride would be inhibition of the
resorptive function. There is ample evidence
that fluoride passes into cells and that it inhibits numerous
enzyme activities and therefore, the concept that metabolic function
might be inhibited when cells are exposed to high fluoride concentrations
is reasonable."
SOURCE: Rich C, Feist E. (1970). The action of fluoride on bone.
pp. 70-87. In: Vischer TL. (1970). Fluoride in
Medicine. Hans Huber, Bern.
3) Osteocytes: Maintaining
the Structural Health of Bone (back
to top)
"The results support the sensory role of the osteocyte network
as the decline in osteocyte lacunar density
in human cortical bone is associated with the accumulation of
microcracks and
increase in porosity with age. Porosity and microcrack
density increased exponentially with a decline in osteocyte lacunar
density indicating that a certain minimum number of osteocytes
is essential for an “operational” network."
SOURCE: Vashishth D, et al. (2000). Decline in osteocyte lacunar
density in human cortical bone is associated with accumulation
of microcracks with age. Bone
26:375-80.
"The impact of losing osteocytes in bone may be great. In
human bone, osteocyte cell death can occur in
association with age and both osteoporosis and osteoarthritis,
leading to increased fragility. Such fragility may be due
to increased brittleness via micropetrosis and/or loss
of the ability to sense fatigue microfracture
and signal to other cell types for repair."
SOURCE: Noble BS, et al. (1997). Identification of apoptotic changes
in osteocytes in normal and pathological human bone. Bone
20:273-82.
"The co-localization of microfractures
and osteocytes fits with the hypothesis that in vivo fatigue damage
could be repaired by remodeling processes triggered by osteocytes."
SOURCE: Muglia MA, Marotti G. (1996). Osteocyte and microfracture
location in human lamellar bone. Bone
19: 155S.
"We believe these experiments support the hypothesis that
osteocytes are critical to regulation of bone formation and resorption.
In contrast to osteoblasts or osteoclasts that must be signaled
to appear, the omnipresent osteocytes are continually subject
to the strain of the matrix and its derivatives such as strain-generated
potentials and shear-induced fluid flow. These cells not only
perceive and respond to local biophysical signals, they must also
be responsive to a vast array of systemic chemical/hormonal signals
of formation and resorption. Somehow these regulatory
signals are perceived by the osteocyte population, and a message
of maintenance, resorption, or formation is produced to retain
a structurally adequate and metabolically efficient skeleton."
SOURCE: Sun YQ, et al. (1995). Mechanically induced periosteal
bone formation is paralleled by the upregulation of collagen type
one mRNA in osteocytes as measured by in situ reverse transcript-polymerase
chain reaction. Calcified Tissue
International 57:456-62.
"[D]ead and degenerating osteocytes were
found frequently in the region of microfractures,
and viable osteocytes appear to be necessary for the optimum mechanical
function of bone. It is possible that osteocytes are involved
in the maintenance of structural integrity at an ultra-microscopic
level and that impaired osteocyte function increases
the tendency for small defects to become microfractures."
SOURCE: Baylink DJ, Bernstein DS. (1967). The effects of fluoride
therapy on metabolic bone disease. Clinical Orthopaedics and
Related Research 55: 51-85.
|